Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP and Chief Medical Officer

EVP & Chief Commercial Officer

EVP & Chief Financial Officer

President and CEO

EVP and General Counsel

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-29	Premium	sold	Premium	Premium	Premium	EVP and Chief Medical Officer
2024-02-26	Premium	sold	Premium	Premium	Premium	EVP & Chief Commercial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	EVP & Chief Financial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-12	Premium	acquired	Premium	Premium	Premium	EVP & Chief Commercial Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	EVP and Chief Medical Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	EVP & Chief Commercial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	EVP and Chief Medical Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	EVP and General Counsel
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	EVP & Chief Financial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	EVP and General Counsel
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-01-16	Premium	sold	Premium	Premium	Premium	EVP & Chief Commercial Officer
2023-12-21	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-21	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-20	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-19	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-19	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-18	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-18	Premium	sold	Premium	Premium	Premium	President and CEO
2023-11-27	Premium	acquired	Premium	Premium	Premium	EVP and General Counsel
2023-11-27	Premium	sold	Premium	Premium	Premium	EVP and General Counsel
2023-06-26	Premium	sold	Premium	Premium	Premium	EVP and General Counsel
2023-06-02	Premium	sold	Premium	Premium	Premium	President and CEO

COLL - Collegium Pharmaceutical Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for COLL